Allen, Kenneth D.
Kiefer, Miranda K.
Butnariu, Madalina
Afzali, Anita https://orcid.org/0000-0002-4397-9576
Article History
Received: 6 January 2022
Accepted: 14 February 2022
First Online: 6 March 2022
Declarations
:
: Anita Afzali is a consultant or speaker for Abbvie, Celgene/Bristol Myers Squibb, Takeda, Janssen and Pfizer. All other authors have no conflict of interests to disclose.
: The study was approved by the Ohio State University institutional review board.
: Given the retrospective nature of the study, a waiver of consent was granted by the Ohio State University institutional review board.
: Given the retrospective nature of the study, a waiver of consent was granted by the Ohio State University institutional review board.